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Stimulation  of  endothelial  cells by cytokines  and  bac- 
terial  lipopolysaccharide  leads  to  activation f the  tran- 
scription  factor NF-KB. NF-KB in  turn  regulates  the  ex- 
pression  of  several  genes  involved  in  the  inflammatory 
reaction, including cell adhesion molecules, interleu- 
kins, and transcription factors. One of these induced 
genes  encodes  an  inhibitor  of  NF-KB, ECI-~/IKB~,  that 
contains  in its 5‘ regulatory  region  six  consensus  bind- 
ing sites for NF-KB. We demonstrate  here  that  these sites 
display  striking  differences  in  their  ability in  vitro to 
bind  to  various NF-KB subunits. In vivo, all six sites con- 
tribute, though to varying degrees, to transcription 
from  the ECI-G/IKBa promoter,  as  demonstrated  by dele- 
tion  and  mutation  analysis.  Among  the NF-KB subunits 
tested p65,  the  p65/p50  heterodimer  and,  to a  lesser ex- 
tent,  c-Rel,  are  able  to  activate  transcription,  whereas 
p50  or  p50/RelB  were inactive.  Since many genes  regu- 
lated by NF-KB contain only one or two DNA-binding 
sites for this  transcription  factor,  the  presence of six 
functional NF-KB-binding sites in  the ECI-6/IKBa pro- 
moter  represents  a  unique  feature  of  this  gene. 
The NF-KBhel family of transcription  factors  plays a pleio- 
tropic role in  the  regulation of gene expression in a wide variety 
of cell types,  including T and B  cells, fibroblasts, EC,’ kerati- 
nocytes, and cells of the monocyte/macrophage lineage (for re- 
views, see Refs. 1-4). Members of the family in  mammals in- 
clude  p65 (Re&, 5-7), p50 (NF-KB-~; 8-11), RelB (I-Rel; 12,13), 
c-Rel(141, and p52 (NF-KB-~, p50B; 15-18), some of which are 
able to form homo- or heterodimers with different binding 
specificity toward  variants of the decameric DNA recognition 
site (‘‘consensus” GGGRNNTYCC), and  with  different  transac- 
tivating  properties (1, 19). Activation of NF-KB occurs in  re- 
sponse  to widely divergent  stimuli,  including  LPS,  viruses,  in- 
flammatory cytokines,  T and B cell mitogens, or physical and 
oxidative stress,  and  leads  to  transcription of genes encoding 
cytokines, cell surface  receptors,  and  acute  phase  proteins,  as 
well as  transcription  factors, most interestingly  including  those 
of the p50 precursor  and of c-rel(20-22). 
Regulation of NF-KBhel activity is mediated by complex for- 
mation of the  potentially active  factor with  an  inhibitory  sub- 
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unit  termed I K B ~  that sequesters  the  transcription  factor(s)  in 
the cytoplasm. I K B ~ s  (MAD-3, pp40, RMF-1,  and ECI-6) have 
been cloned from various species and  shown to interact  with 
the  p65  subunit (23-26). Zn vitro, I K B ~  also blocks binding of 
NF-KB  to  DNA(27). Upon stimulation of the cell, I K B ~  is modi- 
fied, most likely by phosphorylation, leading to dissociation 
from the  NF-KB complex and  subsequent  translocation of the 
transcription factor to  the  nucleus.  The signals leading  to modi- 
fication of I K B ~  presumably involve the  generation of reactive 
oxygen intermediates (28). This system allows, without the 
need for prior RNA or protein synthesis, a very rapid, and 
usually  transient  response of the cell to  environmental  stimuli. 
While the  mechanisms  leading  to  activation of NF-KB  have 
been  studied extensively, until recently  very little  was known 
about how NF-KB could be  down-regulated to  prestimulation 
levels once the responsive genes have been transcribed. We 
have recently cloned a gene  termed ECZ-6 from  cytokine-stimu- 
lated porcine aortic  EC  (24) encoding I K B ~ .  Interestingly, ECI- 
6 f i ~ B a  mRNA is  up-regulated by tumor necrosis  factor a, IL-1 
or LPS,  the  same  agents that activate NF-KB. The  up-regula- 
tion of I K B ~  is antioxidant  sensitive  (24, 291, suggesting  the 
involvement of NF-KB in  its  regulation.  Indeed, ectopic expres- 
sion of p65 in  several cell types  leads to  expression of endog- 
enous I K B ~  (29-32). The  mutual  regulation of NF-KB  and I K B ~  
has led to  the concept of a regulatory circuit, where  the expres- 
sion of I K B ~  by NF-KB  leads  in  turn to inhibition of NF-KB 
(24, 29, 30, 32). 
In  this  report, we demonstrate that this expression is medi- 
ated  through  the  direct  interaction of NF-KB  with six specific 
binding sites in the ECI-6IZKBa promoter. Various in vitro 
translated members of the NF-KB family as well as NF-KB 
from nuclear  extracts of stimulated  EC  bind  to  different de- 
grees  to  these  sites  in EMSA. The  availability of a highly e%- 
cient  transfection  method for EC (transferrinfection)  has  en- 
abled  us  to  evaluate  the in vivo contribution of each  site, as well 
as  the  ability of individual  members of the  NF-KB family to  
activate  transcription from the ECZ-6IZKBa promoter  in  this 
cell type. 
EXPERIMENTAL PROCEDURES 
DNA  Sequencing4enomic clones  containing the 5‘ regulatory  re- 
gion of ECI-GIIKBa were obtained by screening a porcine  genomic li- 
brary  (Clonetech) as previously  described (24). A 5.5-kb  EcoRI fragment 
containing 2.1 kb upstream from the transcription start site was sub- 
cloned and sequenced  using a commercial kit  (United States Biochemi- 
cals  Chemical  Corp.). 
Plasmid Constructs-Expression plasmids  pCMV4TAp65 and 
pC4-85 for human p65 and c-rel, respectively, were  obtained  from Dr. W. 
C. Greene. cDNAs for human p50 and murine relB (plasmids pET3b  and 
relB M2) were from  Dr.  C.  Scheidereit and Dr. R. Bravo, respectively, 
and subcloned into a CMV expression  vector.  RcCMV-p65  used for in 
vitro translation was from Dr. P. A. Baeuerle. A series of deletion or 
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-2114  GAAT  TCCTTATCAG 
-2100  TGAAAATATC  ATTTAAAAAT  AAAGTAATAG  TAGTTGTTTC  CCCAGGTAAT  CACTGAAAAT 
-2040  CCATTGCCTG  TTGACCAGAA  CCAAAATGTG  TATTAAAGGA  AGTTCTTCAG  GCAAAAATTT 
-1980  AGAACTATAA  CCAAAAAAAT  GAGGAGTATT  GGAAAGATCA  TGAATGGAGG  AAATAATGTT 
-1920  TTAATTATCT  TGATGTTTAT  TAGTCTATTC  AAAATGTTAT  TCAAAAACAA  ATATATGGAG 
-1860  ATTTAAAGAA  GGCTAATCCT  TATGTCAGGA  AAGAAGACCT  CACTCATAGG  CTTGTCTCTC 
-1800  ATGATAACCC  AAGAGATAAC  ATTTTTTGAA  CATTTCAACA  ATGCAATTAG  AGAATTATAG 
-1740  GGTTTAGCCC  CAGAATCAGA  AAGAGGTATT  CAGAAAAATC  TATTTTCAAG  TTACACAAGT 
-1680  TTAATTGTTG  GCATTTTGAA  GATGCCCACT  TAATGGTACT  AGAGAAGTTT  CAAGGCAAAC 
-1620  TTACAAAAAT  CTTATATGAT  TATTTGATAC  TGCAACAACT  TGGCTAGTCT  ACTCAGTCAA 
-1560  CATTGTGCAT  GAAAACTTAC  TAAAACTGCT  GATGATATTT  TTTTATCCAT  TTATTCTGCT 
-1500 AATTTTGGTA  AAAAACTATA  AATTTGAGAC  TTGGACAAGA  TCCCAAACCT  CACATTTCCT 
-1440  TTGAATATCT  ACCCATGGTT  ACATGTAACT  ACACTCCTAT  GTGCTGGCCA  ATGTTGTATA 
-1380  ATCACAGGAT  GAACTGAAGC  TTTTCCTTGC  TAAAGAGTTT  TAGCCCTCCA  AGAGTAAGTT 
-1320  ATTCCAATTT  ATCTCTGCAG  CAACAGCAAC  ATTAATTTTC  ATTCAGCTCT  CATAACATAG 
-1260  CTTTTTAAAT  ACTTGCCATT  TTTGAAAAGA  TCCAAGTTGC  TTTATTAGGG  CCTGGACCAT 
-1200  TTCTAGAAGT  AGATGAATGC  ATTCCTTTCA  TTGGCTAGGA  GGTGGGGATG  GGGCAGAGAG 
-1140  CATACTTCTG  TTTCTGCAGC  TGAGACCTGG  ACATGGTGAA  CCTGGAGTAG  CTACCCATAT 
-1080  GGCATGGACA  GGTCCAACTG  CTGCCCCCTC  CTTTGTCCCC  CAAGAAGCCA  GCAGGGGCAG 
-1020  GATGAAGGCC  ACCTTGGGCT  GCCCTGAGCC  TCCTGCAGTA  TGCCTGGCAA  CTACTTTCTT 
-960  AGCCATCTTT  AAGGCCCAAT  CTTGGGTAAA  ATACTACTCA  ACCCATTCTT  TAGCCACCTT 
-900  CTCCAAATGC  TTCTAGAAAG  CGGCCCCCAC  AAGTAGGTTC  TCTGCAGCAG  CACAGTGCAA 
-840  ATGGAGGAAC  ACGACCTCAG  TAATTATTTT  GTCACTGCAA  AGTATCTACA  ACCTTTGCTA 
-780  TAAAAATTAA  CACCTTGCTT  TCCCTGAAAA  ATAGCCCAGT  CATATCCAGC  ATTTTCCAGC 
-720  ATCCAGGGCA  GAGTGCTTGC  TCCTCCCCCA  GTCAACAGGA  CTGTTCATAC  CGAGNAAATG 
-660  ATTTGAGGGT  TCTCTAAGCA  TTTACGCTGT  TAATGCTAAA  GCTTTCACGA  CTTCTACCTG 
-600  AGGGGGGCTT  GAGGGAGGGG  GGAGGTTTAT  GTCCCTGCAC  TGCCAGGAGC  CTGGTCTTTG 
-540  GTAGGAACGC  AGAGGCAGCC  GGCGACCTTC  CACCCTCAGT  GTGTCCTTCC  CCAGGAGTTT 
-480  AGGGAAGTGA  ATCCCTAGAT  CCAGCCAACA  TTTCCACTCC  CATTTTCAAG  AGATTAAAAA 
-420 AAAAAAAAAA AAAAAAAAAG  GAAAGClATCG  GCAGGTCAGC  AAACCAGCAG  TTCTCCATCC 
-360 TJ’GGGATCTT  AGCAGCCGAC  GACCCCAAAT  CAAATCGATC  GTGGGAAACC  CCAGGGAAAA 
-300  TAAGGTTCCA  TGCAGAGGGC  CAGGATTACT  GACTGCAGGC T CAGGG-GGGGGA 
BS 6 BS 3 
BS I 
-240  GGGGGCCGGG  TCGGGAGGAC  TTTCCAGCCA  CTCAGCGTGC  ATTAJ’AAAGT  TCCCTGTACA 
BS 1 BS 8 
-180  TGACCCCAGT  GGCTCATCGC  AGGGAGTTTC  TCTGATGAAC  CCGGGCGCGG  GGTTTAGGCT 
BS 5 
-120  TCTTTTTCCC  CCAGCAGAGG  ACGAGGCCAG  TTCTCTTTTC  TGGTCTGACT  GGCTTGGAAA 
-60  TTCCCCGAGC  TTGACCCCGC C AG- TCCCCTGCCA  GCGTTTATAG  GGCCGCGGCG 
BS 2 BS 4 +1 
FIG. 1. Nucleotide  sequence of the upstream regulatory region of ECZ-GllrcBa. Numbering of nucleotides is shown  on the left and starts 
a t  the transcription start site ( + I ) .  The eight motifs (BSI-8) with homology to the NF-KB consensus sequence that were further analyzed are 
underlined, and the TATA  box is indicated in bold. 
pression vector UBT.Luc (33) was prepared by subcloning at  appropri- gene from PAEC which is not regulated at the transcriptional level)’ 
ate restriction sites or by polymerase chain reaction. All constructs were  immobilized on  nylon membranes (Hybond-N, Amersham Corp.). 
confirmed by  DNA sequencing. In Vitro Dunscription  and Dunsla -For  n  vitro transcription, 
Nuclear  Run OR Dunscription Assay-Nuclear run off experiments the cDNAs for  p50 and c-re1 were  subcloned into pKSM13, and for  p65 
were  performed as described (34). Nuclei  were isolated from 3 x lo7 the plasmid RcCMV-p65 was used. Ten pg of each plasmid were linear- 
porcine endothelial cells (PAEC), either unstimulated or stimulated ized and transcribed using T7 or T3 RNA polymerase (Stratagene)  in a 
with LPS (100 ng/ml)  for 1 and 3 h. Equal numbers of countdminute of 
radiolabeled RNAwere hybridized to cDNAprobes (ECI-~/IKB~,  human 
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TAR1.E I 
Sequences and  locations of consensus NF-KB binding motifs 
in  the ISCI-GIKBa promoter 
Site Location Sequence Homology 
% 
BS 1 -215 AGGACTTTCC 90 
BS  2 -55 GGAAATTCCCC 90 
BS 3 -305 GGGAAACCCC 100 
BS 4 
BS 5 
-30 GAGAAATCCCC 90 
-150 GGGAGTTTCTC 90 
BS 6  -350 GGGATCTTAGC 80 
BS 7 -245 GGGAAGTACC 90 
BS 8 - 185 AAAAGTTCCC 70 
NF-KB  consensus GGGRNNYYCC" 
R = A or G; Y = C or T. The NFKB consensus  sequence  is  taken from 
Baeuerle  (1991). 
LPS-Induction Time (h) 
E C I - 6  
A c t i n  
GAPDH 
E C I - 1  2 0 0 0 
FIG. 2. Nuclear run off analysis. Radiolabeled RNA was  prepared 
A 
B 
from nuclei  isolated from porcine aortic  endothelial  cells  (PAEC)  stimu- 
lated  with  LPS  (100  ng/ml) for 0, 1. and 3 h. and  hybridized to immo- 
bilized  cDNAprobes for EcI-6f l~Ba  and,   as  controls, for human  p-actin, 
rat  glyceraldehyde-3-phosphate  dehydrogenase,  ndECI-12 (an  un- t . I , ' h -  
characterized  gene from PAEC that  is  not  regulated  at  the  transcrip- 
tional  level).2 FIG. 3. Electrophoretic mobility shift assay of NF-KR binding 
to the BS swuences in the ECI-~YIKRCI Dromoter. A. competltion 
total  volume of 100 pl. including  0.25 mM m7G(5')ppp(5')G. After DNase 
I treatment, 1/20 of the purified RNA was  translated  in  50 p1 of wheat 
germ extract (Promega). Parallel reactions including ["Slmethionine 
were  carried  out  to  confirm  the  correct  size of the  translated  products by 
analysis on SDS-PAGE (data not  shown).  For  cotranslation of p50 and 
p65, a coupled transcription-translation system (TNT, Promega) was 
used. 
Nuclear  Extracts and  Electrophoretic Mobility Sh ip  Assays-Nuclear 
proteins from porcine  aortic  endothelial  cells  stimulated  with  100 ng/ml 
LPS  for  2  h or from non-stimulated  cells  were  extracted as  described 
(35).  The  double-stranded  oligonucleotide  probes  were  labeled by filling 
in  the EcoRI overhangs  with Klenow enzyme  in  the  presence of 
["PldATP. and  0.2  ng (30,000 countdminute) used  per  lane  in EMSA. 
The  sequences of oligonucleotides  used for EMSA were as  follows (5' to 
3'. only the  top  strand is given): BS1, AATTCGTCGGGAGGACTITC- 
CAGCCAG; BS2, AA~CGGCTTGGAAATTCCCCGAGCG; BS3. AAT- 
AATCCCCTGCCAG; BS5, AATTCATCGCAGGGAGTITCTCTGATGG; 
GAAGTACCGGGGG; and BS8. AATTCATTAtUAAG'ITCCCTGTACG; 
IgKB, a NF-KB-binding site from the  human immunoglobulin K light 
chain enhancer (36): AATTCAGAGGGGGATITCCCAGAGG; mKB. a 
mutated NF-KB site: AGCTTAGAT'MTACTITCCGAGAGGA. A 100- 
fold molar  excess of unlabeled  oligonucleotides  was  used for competition 
experiments.  The  resulting  complexes  were  separated on 5 6  polyacryl- 
amide gels. Polyclonal rabbit anti-p65, anti-p50, and anti-FosB anti- 
bodies were obtained from Santa Cruz Biotechnology, CA. and 1 pg 
added to the  binding  reaction 30 min before addition of the probe. 
W Cross-linking-Experiments were performed as  described (37). 
Briefly, 15 pg of nuclear  extract from EC stimulated  with  LPS for 2  h 
were  incubated  with  1.5 x lofi countdmin of a BrdU/["'PldATP-labeled 
(top  strand) oligonucleotide  representing  the BS2 site. After gel electro- 
phoresis, the protein-DNA complexes were covalently cross-linked by 
ultraviolet  irradiation  (302  nm),  digested  with  DNase I. eluted from the 
gel,  and  analyzed by SDS-PAGE and  autoradiography. 
Dansfections and  Reporter Gene Assays-EC were  isolated from pig 
aorta  as described  (38),  grown  in  complete Dulbecco's modified Eagle's 
medium ( 2 6  sodium  pyruvate, 1% [.-glutamine  (Life Technologies, Inc.), 
10% heat-inactivated  fetal  calf  serum,  and  antibiotics)  and  transfected 
TCGATCGTGGGAAACCCCAGGG AG; BS4. AATTCGCCCAGGAGA- 
BS6, AATTCTCCTTGGGATC'ITAGCAGCCG; BS7, AATTCTGCAGG- 
experiments:  nuclear  extract from porcrnr aortlc  endothelial cells 
(PAEC)  stimulated  with  LPS for 2 h  (Extract L I was probed for hinding 
to the labeled NF-KB binding site BS2 (lane 2 ) .  I a n r  1. labeled RS2 
probe alone. Binding was competed with a 100-fold molar rxcess of 
unlabeled  oligonucleotides  representing  binding sites 1- A as  indicated 
in lanes 3-10 (BSl-BSA, see  Table I ) .  Specificlty of binding  was  dem- 
onstrated by competition  with  a  mutated NF-NR site ( m d ,  lanr I 1  ) or 
with a NF-KB site from the immunoglobulin K light chain enhancer 
(lane 12). B .  binding of proteins from nuclear  extract from LPS-stimu- 
lated PAEC to  individually  labeled  oligonucleotides RS1-5 and  7 ( l a w s  
1 ,  4 ,  7, IO. 13, and 16) .  Competitions with the respective unlabeled 
probes (lanes2.5,R,II,14, and 1 7 )  and  with  a  mutated NF-rR site mrtR 
(lanes 3, 6, 9, 12. 1.5. and 1 8 )  are  shown. 
using the transfemnfection method (39. 40). Briefly, confluent EC in 
6-well plates were incubated for 2.5 h with a complex consisting of 
transfemn/poly([.)lysine/adenovirus containing  a  total  amount of 3 pg of 
plasmid DNAs, including  Rous  sarcoma  virus.pgal as  internal control. 
in 1 ml ofcomplete  medium,  then  washed once with Dulbecco's modified 
Eagle's medium, and grown further for 40 h. Luciferase levels were 
determined  and  expressed  as  relative  light  units  normalized for pna -  
lactosidase  expression  (41 ). 
RESULTS 
Mult iple   NF-&-binding  Si tes  (BSI Are Present  in  the  Pro- 
moter Region of ECI-6IIKBa-We have previously isolated 
genomic  clones  of ECI-GII&a and   de t e rmined  the transcrip- 
t ion start s i te   by   p r imer   ex tens ion   and  RNase protection (24). 
2.1 kb of the upstream  regulatory  region are shown  in  Fig.  1. By 
searching  for NF-KB-binding sites us ing  the consensus motif  
GGGRNNTYCC (l), eight  potent ia l  s i tes  (designated RS14) 
were found within the first 400 base pa i rs  ups t ream of the 
transcription start s i te ;   no NF-KB binding motifs were found 
fur ther  upstream. Sequences and locat ion of these  s i tes  are 
given  in  Table I .  
Induct ion  of ECI-GII&a Is Regu la tpd   a t   t he   Danncr ip t iona l  

















Summary of the  binding  properties of BS sites  to  nuclear  extract  and 
individual NF-KB subunits 
( + I  
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a No quantification  is  given; ND. not  determined; (+) weak  binding. 
A 
Extract II + I + I + I 
Rokl BS2 I BS2 [ BS? I B 
FIG. 5. 
B 
FIG. 4. Differential binding of in vitro translated membera of 
the NF-KB family to the different NF-&-binding sites.A. p50 and 
c-Re1 were produced by in tvrfro translation in a wheat germ extract, 
incubated  with  labeled RS1-5 or 7 probes  and  separated on polyacryl- 
i J  
B 
ta 
t t  
D65 and DM) are Drenent in nuclear extra& of Lps 
stimulated EC. A. bartial in'hibitlon of the  binding of nuclear  extract 
to the BS2 probe by anti-p6S  and  anti-p50  antibodies. Before the  addi- 
tion of the labeled BS2 probe. the  binding  reaction  was  preincubated 
either  with  anti-p65 (p6.5 I ,  anti-p50 ( p 5 0  1, or  with  a  control  antibody 
( C ) .  Competitors RS2 and mKR were as  in Fig. .?A. R .  cross-linking of 
proteins binding to the RrdUP*P-labeled double-stranded RS2 ollgo- 
nucleotide. After preparative EMSA, the gel was irradlated with W 
gested  with  DNase,  and analyzed by SDSPAGE. 
light, protein complexes linked to the oligonucleotide recovered, di- 
sis factor a, IL-1, and LPS (24). To determine whether this  
inducible  mRNA  accumulation  is  due to transcriptional  activa- 
tion,  nuclear  run off experiments  were  performed  using  nuclei 
from  porcine EC treated  with  LPS (Fig. 2). ECI-GIIKUU is ac- 
tively  transcribed  in  LPS-stimulated EC, whereas  no  specific 
transcripts are detectable  in  the  nuclei of unstimulated  cells. 
Scanning of the  nuclear  run off and  the  Northern blot (24) a t  
1-h  post-stimulation  revealed a 8.1- and 8.5-fold increase of the 
newly  synthesized  and of the  steady-state  levels,  respectively, 
amide  gels (lanes I ,  4.  7, 10, 13. 16, 19. 22. 25. 28, 31. and 341. Speci- 
ficity of the  binding  was  demonstrated by competition  with the respec- 
tive  unlabeled  probes (lanes 2. Fi. 8. 11.14,  17.20.23,26.29.32. and .?5 1 
33, and 36). B. binding of BS1 (lanes 1-31, RS2 (lanes 4 4 ) ) .  RS3 (lanes 
and  with a mutated NF-KB site (lanes 3. 6.9. 12. 1.5. 18.21.24.27.30. 
7-9). and BS4 (lanes 10-12) to in  vitro translated pS0 and p6S. p.50 and 
p65  were  translated  either  individually or cotranslated  in  wheat  germ 
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indicating tha t   ECI-~/ IKB~ mRNA accumulation is almost ex- 
clusively due to transcriptional regulation (data not shown). 
Multiple Sites in the ECI-6IIKBa Promoter Can Bind NF-KB 
in Vitro"BS2 has already been established as a hct ional  in 
vitro binding site for NF-KB by  EMSA studies (24). To evaluate 
the other BS sites as functional elements, we have used unla- 
beled  oligonucleotides representing each BS sequence to com- 
pete with the labeled BS2 site in EMSA. Fig. 3A shows that 
BS1, 3, 4, 5 ,  and 7, as well as a NF-KB site from the immuno- 
globulin K light chain enhancer (IgKB) are able to compete with 
the labeled oligonucleotide BS2 site to varying degrees. BS6, 
BS8, and a mutated NF-KB (mKB) site do not compete. Indi- 
vidual labeling of BS1, 3, 4, 5 ,  and 7 confirmed their ability to 
bind NF-KB from nuclear extracts, with the respective binding 
capacities corresponding to the  results from the competition 
experiments. 
The BS Sequences in the ECI-6IIKBa Promoter Display Dif- 
ferent Binding Specificity  Toward Individual Members of the 
NF-KB Family-Different NF-KB subunits have been  shown to 
specifically  bind to certain  target sequences but not others  (42). 
Therefore, p50 and c-Re1 were in vitro translated  in wheat germ 
extract  and probed  for binding to labeled sites BS1,  2, 3, 4, 5 ,  
and 7. Fig. 4A shows that p50  specifically binds to BS2, 3, 4, 
and 7, but not to BS1 and 5 (the weak and atypical interaction 
with BS5 was not scored as positive). c-Re1 binds preferentially 
to BS1,  2, and  3, with no detectable binding to BS4, 5,  and 7. 
Since in EC as well as  in many other cell types the predomi- 
nant species of NF-KB is  the p50-p65 heterodimer, we have 
translated  these two subunits  either individually or cotrans- 
lated  them in vitro in a coupled transcription-translation reac- 
tion, and assayed for their binding ability to BS1 to 4. Binding 
of p65 was observed predominantly to the BS2 site (Fig. 4B); 
BS1,3,  and 4 displayed weak binding, which, in the case of BS1 
and 4, was visible  only aRer longer exposure. Only low levels of 
the heterodimer were observed at all  sites  tested;  this however, 
might rather reflect the smaller extend of heterodimer forma- 
10 - 
8 -  
6 -  
4 -  
2 -  
0- 
- 
tion between p65 and p50 than  the affinity of binding (see 
below). A compilation of the results from the EMSA studies  is 
given in Table 11. 
Nuclear Extract from LPS-stimulated EC Contains p65 and 
p50-To address  the question, which members of the NF-KB 
family are present in the nuclear extracts from LPS-stimulated 
EC, supershift, and UV-cross-linking experiments were per- 
formed. As shown in Fig. 5A,  binding of NF-KB from nuclear 
extract to the BS2 site  is partially inhibited both by anti-p65 
and  anti-p50 antibodies, but not by a control (anti-FosB) anti- 
body, suggesting that  the extract from LPS-stimulated endo- 
thelial cells contains p65 and p50.  Upon  UV-cross-linking (Fig. 
5B)  of bound proteins from EC nuclear extract to the BS2 site, 
DNase digestion, and resolution on denaturing PAGE, two 
bands of 50 and 65 kDa are detected, indicating the presence of 
p65 and p50 NF-KB subunits in LPS-stimulated EC. 
Expression of an ECI-6IIKBa Promoter-Reporter Fusion 
Gene Is Dependent on the  Presence of thep65 Subunit or c-Rel- 
The distinct in vitro binding activity of each BS to different 
members of the NF-KB family prompted investigation of the in 
? vivo interaction between the E C I - ~ / I K B ~  promoter and various < m a E m z ? m  . - o m -  
2 0 0 > * -  o - o NF-KB proteins. An E C I - ~ / I K B ~  promoter-luciferase reporter , o o o 8 1 . , g u Y  
- 
o e e  
g ( D a ( D a : ( D , s g :  fusion plasmid (p600) containing all of the BS sequences was 
n 0 
a 0 cotransfected into EC together with CMV promoter-driven ex- n g a  a a pression vectors carrying genes for either p50,  p65,  c-Rel, or 
F ~ ~ .  6. ~~~~~i~~ ofan E C I ~ ~ ~  pmmotelrrep~r gene by h l B ,  or with a combination of p50 plus each of the other 
different members  of the NF-& family. An ECI-MKB~ promoter- members (Fig. 6). In EC, transfection with p50 or relB did not 
luciferase reporter gene construct, ~ 6 0 0  (see Fig. 7) was cotransfected induce the expression of the reporter gene, whereas p65 alone 
into EC together with expression vectors for various NF-KB subunits as was able to confer a than 300-fold increase of luciferase 
indicated. All transfections included an Rous sarcoma virus.pga1 ex- 
pression vector as internal control. CDA1, control expression vector. as compared with control  evels.  Addition of  P50 re- 
Luciferase activity was determined 40 h later and  normalized for  p-pa- sulted in a further 2-fold increase. A lower  (60-fold) stimulation 
lactosidase expression. of luciferase activity was induced by c-Rel. Cotransfection of 
"XI -500 -400 -300 -200 -100 + I  
I I I I I I I  
FIG. 7. Mutation analysis of the BS 
sequences in the ECI-6/IKBa pro- 
moter. various EC1-6fi~Ba promoter de- 
letion and substitution mutants were  pre- 
pared as described  under  "Materials  and 
Methods"  and  are presented schemati- 
cally on the left with the positions of the 
BS motifs indicated. All constructs were 
cotransfected together with an expression 
vector for p65 into EC. BSlm and BS2m, 
mutated BS1 and BS2 sites, respectively; 
BS1+2m: BSllBSP double mutation; 
pUMS, control luciferase vector. Lucifer- 
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p50 with C-Re1 provided a further 1.5-fold activation above that 
seen with c-Re1 alone. 
Deletion and  Mutation Analysis of Different NF-&-binding 
Sites-% define the contribution of each BS to NF-KB-medi- 
ated activation, a series of deletion or substitution  mutants was 
prepared. The resulting plasmids are presented schematically 
in Fig. 7. Each construct was cotransfected with an expression 
vector for p65 into EC. Sequential deletion of BS3, 7, and 1 
resulted in a gradual loss of p65-mediated expression of the 
reporter gene, with less additional reduction when deleting the 
BS5 site. Deletion of the 300-base pair fragment upstream of 
the BS3 site also resulted in a 40% reduction of luciferase 
expression. This effect might be due to deletion of the BS6 site. 
BS6 by itself did not show detectable binding in EMSA but 
could still be functional in uiuo. Additional mutation of BS2, 
leaving only BS4 intact, almost completely  abolished expres- 
sion. In the p260 construct, mutation of either BS1 or BS2 
caused a more marked decrease in expression than deletion of 
BS7. Mutation of both BS1 and 2, leaving BS4, 5, and 7 intact, 
reduced expression to base-line levels, indicating that these 
two sites are of particular importance. 
DISCUSSION 
NF-KB is a key transcription factor involved in both transient 
and constitutive expression of various genes elicited by diverse 
external  stimuli  and  in a variety of cell types. While constitu- 
tive expression in lymphoid tissues correlates with the pres- 
ence of  p5OIRelB heterodimers, the p65-p50  complex is usually 
involved in transient gene expression (43). The activation of 
p65/p50-NF-~B is achieved by phosphorylation, dissociation, 
and subsequent degradation of a cytoplasmic inhibitor, I K B ~  (1, 
44). Recent studies on I K B ~  have shown that,  in various cell 
types, transfected NF-KB is able to subsequently induce the 
endogenous mRNA and protein synthesis of its own inhibitor, 
IKBa (29, 30, 32), and that  the reappearance of I K B ~  protein 
correlates with the disappearance of nuclear NF-KB binding 
activity (29). These findings have led to the concept of a regu- 
latory circuit between NF-KB  and I K B ~  that provides a dynamic 
feedback mechanism to ensure the  transient  nature of NF-KB 
induction. 
In  support of this view,  we demonstrate here that induction 
of the  ECI-G/IKB~ promoter is directly regulated by distinct 
members of the NF-KB family. We characterized six potential 
NF-KB-binding sites (BS1, 2, 3, 4, 5, and 7), which bind to 
varying degrees to LPS-induced NF-KB from nuclear extracts of 
EC and to in  vitro translated  NF-KB  subunits n EMSA (Figs. 3 
and 4). Zn viuo, all six BS sites contribute to different degrees to 
expression of the E C I - ~ / I K B ~  gene. 
Cotransfection of expression vectors for  p50 plus p65 induced 
strong  transcriptional activation of the E C I - ~ / I K B ~  promoter- 
reporter gene  (Fig. 6), consistent with the view that p50lp65 is 
the physiologically  most relevant factor for transient  transcrip- 
tional activation in most cell types. Transfection of the p65 
subunit was able to evoke  40% of the expression seen with p65 
plus p50. This could be due to an excess of endogenous p50 
constitutively present  in the cells.  However, we have not de- 
tected ~SO-NF-KB binding activity in  the nuclear extracts of 
non-stimulated cells by  EMSA (data not shown). Alternatively, 
p65  could lead to expression of p50, as  this  has been  demon- 
strated  in  Jurkat cells (20)  and subsequent formation of the 
heterodimer. In  the case of the VCA"1 enhancer, both p65 and 
p65Ip50 can activate transcription: low concentrations of p65 
were found to act  in concert with p50, whereas at high concen- 
trations, p65 alone could stimulate  transcription (45). A similar 
mechanism could  be operative in the E C I - ~ / I K B ~  promoter. 
It is worth noting that  in our experiments NF-KB, either  in 
the form of the p65-p50 heterodimer, or as  the p65  homodimer, 
was alone sufficient to induce expression from the   ECI -~ / IKB~ 
promoter. Other transcription factors, such as--1,  HMG I(Y), 
or C/EBP, that have been described to act in concert with 
NF"KB in  the regulation of other genes (4648), seem not to be 
necessary. SP-1 might be an exception, since a potential bind- 
ing site for this factor is located at position -44 to -39; In  the 
HIV-1 enhancer, SP-1  has been demonstrated to interact with 
NF-KB to mediate inducible transactivation (49). 
One or two NF-&-binding sites are present in the 5' regu- 
latory regions of several genes relevant for EC activation, e.g. 
those encoding the cell adhesion molecules ELAM-1 and 
VCA"1 (45, 50-52) or the cytokines IL-6 and IL-8 (53-56). 
Therefore, the presence of multiple NF-KB-binding sites  in the 
ECI-G/IKB~ promoter is unexpected; all six sites are functional 
in uitro and contribute, although to different degrees, to p65- 
and p50-p65-mediated ECZ-6IIKBa expression in EC.  Since the 
NF-KBDKB~ system is not restricted to EC, the presence of 
these multiple sites offers the possibility, that in other cell 
types, or in response to different stimuli, other members of the 
NF-KB family (including not yet discovered members) might be 
operative that preferentially utilize certain of the BS sites. In 
support of this view,  we find that c-Rel, as compared with p65, 
displays a different preference toward certain  sites in vitro. 
Alternatively, the number of binding sites in a promoter 
might influence the quality of the response to a transcription 
factor. In a different system, transcription levels  from  five tan- 
dem  GAIA-binding sites followed a sigmoid curve in response 
to increasing amounts of GAIA-VP16,  showing a "threshold" 
effect in response to low levels of the transcription factor (571, 
whereas one or two sites yielded a linear response.  Correspond- 
ingly, the presence of multiple &-binding sites  in the ECI-61 
I K B ~  promoter might result  in a more  pronounced  yes/no re- 
sponse of the gene depending on the concentration of NF-KB. 
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